Company Legal Name
Latest Valuation
Founded Year
Headquarters
XtalPi Inc. develops an integrated software and robotics platform that leverages artificial intelligence to accelerate drug discovery and materials research and development. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company combines quantum physics, AI algorithms, and automated laboratory systems to predict molecular properties and optimize pharmaceutical compounds. XtalPi's platform enables pharmaceutical companies and research institutions to reduce development timelines and costs by providing computational predictions validated through robotic experimentation. The company serves clients across the global pharmaceutical and materials science sectors, positioning itself at the intersection of computational chemistry and laboratory automation to transform traditional R&D workflows.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
